ROLE OF GRANISETRON IN MINIMISING USE OF MEPERIDINE AS A RESCUE DRUG FOR POST SPINAL SHIVERING

Authors

  • Maheen Wahid Department of Pharmacology, Army Medical College, National University of Medical Sciences, Rawalpindi-Pakistan https://orcid.org/0000-0003-1500-0671
  • Shabana Ali Department of Pharmacology, Army Medical College, National University of Medical Sciences, Rawalpindi-Pakistan
  • Mudassar Noor Department of Pharmacology, Army Medical College, National University of Medical Sciences, Rawalpindi-Pakistan
  • Kulsoom Farhat Department of Pharmacology, Army Medical College, National University of Medical Sciences, Rawalpindi-Pakistan

DOI:

https://doi.org/10.55519/JAMC-04-11651

Keywords:

Granisetron, Spinal, Anaesthesia, Shivering, Meperidine

Abstract

Background: Shivering is one of the most common adverse outcomes associated with the administration of spinal anaesthesia, which, when clinically relevant, leads to numerous detrimental effects on the human body. Hence, its management becomes imperative. Meperidine, an opioid analgesic, is the drug of choice for this condition. However, the use of meperidine is controversial, as it carries the devastating adverse effect of respiratory depression. We explored the role of granisetron, a 5HT3 antagonist and a commonly used antiemetic premedication, in minimising the incidence of post-spinal shivering and decreasing the use of meperidine as a rescue drug. Methods: Overall, 160 parturient patients, between the ages 18–50, undergoing uncomplicated, elective caesarean section, were enrolled in the study, and randomized into two groups with 80 participants each: Group A received 3ml of normal saline, and Group B was administered 3 mg granisetron,15 minutes prior to spinal anaesthesia institution. Incidence of clinically relevant shivering (score of 3 or more) was noted, and it was recorded whether meperidine was used or not. Results: 67.5% of participants in Group A, and 32.5% of patients in Group B, experienced clinically relevant shivering, with 62.5% of patients in Group A and 28.75% in Group B warranting the use of meperidine. There was a statistically significant difference between the two groups in terms of incidence of clinically relevant shivering, and meperidine consumption (p-value <0.001). Conclusion: Premedication with 3 mg granisetron effectively attenuates the occurrence of post-spinal shivering and, hence, lowers the requirement of meperidine as rescue medication.

References

Capdevila X, Aveline C, Delaunay L, Bouaziz H, Zetlaoui P, Choquet O, et al. Factors determining the choice of spinal versus general anesthesia in patients undergoing ambulatory surgery: results of a multicenter observational study. Adv Ther 2020;37(1):527–40.

Luggya TS, Kabuye RN, Mijumbi C, Tindimwebwa JB, Kintu A. Prevalence, associated factors and treatment of post spinal shivering in a Sub-Saharan tertiary hospital: a prospective observational study. BMC Anesthesiol 2016;16(1):100.

Arnold JT, Hemsley Z, Hodder SG, Havenith G, Lloyd AB. Reliability and validity of methods in the assessment of cold-induced shivering thermogenesis. Eur J Appl Physiol 2020;120(3):591–601.

Lopez MB. Postanaesthetic shivering–from pathophysiology to prevention. Rom J Anaesth Intensive Care 2018;25(1):73–81.

Buggy DJ, Crossley AW. Thermoregulation, mild perioperative hypothermia and post-anaesthetic shivering. Br J Anaesth 2000;84(5):615–28.

Zhang J, Zhang X, Wang H, Zhou H, Tian T, Wu A. Dexmedetomidine as a neuraxial adjuvant for prevention of perioperative shivering: Meta-analysis of randomized controlled trials. PLoS One 2017;12(8):e0183154.

Isngadi I, Jaya W, Fardian D. The effect of low-dose granisetron on shivering in subarachnoid block. Bali J Anesth 2019;3(3):166.

Boyle JM, McCall KL, Nichols SD, Piper BJ. Declines and pronounced regional disparities in meperidine use in the United States. Pharmacol Res Perspect 2021;9(4):e00809.

Kothari S, Porwal S, Gupta CM, Nigam AK. Comparative evaluation of Ondansetron and Granisetron in combination with Dexamethasone for the prophylaxis of chemotherapy and radiation induced emesis in cervical cancer patients: A prospective study. Int J Health Clin Res 2021;4(11):23–7.

Nallam SR, Cherukuru K, Sateesh G. Efficacy of intravenous ondansetron for prevention of postspinal shivering during lower segment cesarean section: A double-blinded randomized trial. Anesth Essays Res 2017;11(2):508–13.

Biswa D, Sharma A, Gogna RL. Comparative assessment of clonidine and tramadol on post-spinal anaesthesia shivering among patients with lower abdominal and lower limb surgeries. IJMA 2021;4(2):130–2.

Khajuria K, Farooqi AK. Efficacy of granisetron in the prevention of shivering during caesarean section under spinal anaesthesia. JMS SKIMS 2020;23(Suppl 1):573.

Abdelsalam Y. A comparative study between pethidine, granisetron and tramadol in prophylaxis against perioperative shivering after spinal anesthesia. Int J Med Arts 2020;2(1):292–300.

Abotaleb UI, Abdalla AM, Abdelrahman AS, Gad GS, Elsayed AM. Dexmedetomidine versus granisetron for the management of postspinal shivering. Ain-Shams J Anaesth 2016;9(4):517.

Gargari RM, Anvari HM. Effect of Different Doses of Granisetron on Preventing Postoperative Shivering in Patients undergoing Septorhinoplasty under General Anesthesia. Adv Biosci Clin Med 2017;5(2):21–6.

Dehghanpisheh L, Azemati S, Hamedi M, Fattahisaravi Z. The effect of 1-mg versus 3-mg granisetron on shivering and nausea in cesarean section: a randomized, controlled, triple-blind, clinical trial. Braz J Anesthesiol 2021;72(4):457–65.

Morgan GE, Mikhail MS, Murray MJ. Clinical Anesthesiology. 6th ed. New York: McGraw-Hill; 2018.

Additional Files

Published

2023-10-10

Issue

Vol. 35 No. 4 (2023): JOURNAL OF AYUB MEDICAL COLLEGE ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Copyright (c) 2023 Maheen Wahid, Shabana Ali, Mudassar Noor, Kulsoom Farhat

Creative Commons License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.